134 related articles for article (PubMed ID: 19032374)
1. Modified ELISPOT assay may predict T-cell hyporesponsiveness to non-inherited maternal antigens.
Taniguchi K; Shimazaki C; Ochiai N; Maruya E; Akatsuka Y; Ashihara E; Maekawa T; Taniwaki M; Saji H
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e163-8. PubMed ID: 19032374
[TBL] [Abstract][Full Text] [Related]
2. No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals.
van den Boogaardt DE; van Miert PP; Koekkoek KM; de Vaal YJ; van Rood JJ; Claas FH; Roelen DL
Hum Immunol; 2005 Dec; 66(12):1203-12. PubMed ID: 16690407
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
[TBL] [Abstract][Full Text] [Related]
4. Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model.
Araki M; Hirayama M; Azuma E; Kumamoto T; Iwamoto S; Toyoda H; Ito M; Amano K; Komada Y
J Immunol; 2010 Dec; 185(12):7739-45. PubMed ID: 21078914
[TBL] [Abstract][Full Text] [Related]
5. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation.
Teshima T; Matsuoka K; Ichinohe T
Arch Immunol Ther Exp (Warsz); 2006; 54(3):165-72. PubMed ID: 16652218
[TBL] [Abstract][Full Text] [Related]
6. The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.
Chen J; Schmitt A; Bunjes D; Chen B; Schmitt M
Int J Oncol; 2007 May; 30(5):1119-27. PubMed ID: 17390013
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
Meng XJ; Lin MF; Cai Z
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
[TBL] [Abstract][Full Text] [Related]
8. Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation.
Ichinohe T; Teshima T; Matsuoka K; Maruya E; Saji H
Curr Opin Immunol; 2005 Oct; 17(5):546-52. PubMed ID: 16084712
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
Koh LP; Rizzieri DA; Chao NJ
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
[TBL] [Abstract][Full Text] [Related]
10. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
11. ELISPOT cell rescue.
Meiklejohn DA; Karlsson RK; Karlsson AC; Chapman JM; Nixon DF; Schweighardt B
J Immunol Methods; 2004 May; 288(1-2):135-47. PubMed ID: 15183092
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
Sykes M
Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
[TBL] [Abstract][Full Text] [Related]
13. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
Davies JK; Koh MB; Lowdell MW
Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
[TBL] [Abstract][Full Text] [Related]
14. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
Schiff SE; Buckley RH
J Immunol; 1987 Apr; 138(7):2088-94. PubMed ID: 2881966
[TBL] [Abstract][Full Text] [Related]
15. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.
Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
Immunology; 2007 Apr; 120(4):456-66. PubMed ID: 17229266
[TBL] [Abstract][Full Text] [Related]
16. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM
Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488
[TBL] [Abstract][Full Text] [Related]
17. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
[TBL] [Abstract][Full Text] [Related]
18. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
19. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
[TBL] [Abstract][Full Text] [Related]
20. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
